February 2, 2017
Tomonori Izawa, Director, Compliance and Narcotics Division, Pharmaceutical Safety and Environmental Health Bureau, MHLW The Ministry of Health, Labor and Welfare (MHLW) said on February 1 that it will wrap up its pharmaceutical compliance investigation into Harvoni (ledipasvir + sofosbuvir)...read more